This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Role of NEMS for Post ICU Rehabilitation

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2015 by Serafim Nanas, University of Athens.
Recruitment status was:  Active, not recruiting
Information provided by (Responsible Party):
Serafim Nanas, University of Athens Identifier:
First received: October 21, 2012
Last updated: June 17, 2015
Last verified: June 2015
The purpose of this study is to investigate the role of NEMS as a rehabilitation tool for muscle weakness following critical illness. The investigators hypothesized that NEMS combined with exercise rehabilitation will have a beneficial role in restoration of muscle strength

Condition Intervention Phase
Critical Illness Procedure: NEMS Procedure: Sham Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Role of Neuromuscular Electrical Stimulation as a Tool for Post ICU Rehabilitation

Resource links provided by NLM:

Further study details as provided by Serafim Nanas, University of Athens:

Primary Outcome Measures:
  • Muscle strength [ Time Frame: up to 2.5 years ]

Secondary Outcome Measures:
  • Duration of hospital stay [ Time Frame: up to 2.5 years ]
  • Functional ability [ Time Frame: up to 2.5 years ]
    Functional ability will be assessed with the FIM score

  • Quality of life [ Time Frame: up to 2.5 years ]

Other Outcome Measures:
  • Muscle strength in patients with ICU acquired weakness (ICUAW) at ICU discharge [ Time Frame: up to 2.5 years ]
    In the subgroup of patients diagnosed with ICUAW improvement in muscle strength will be assessed in patients of the NEMS group as compared to the sham-NEMS group

Estimated Enrollment: 120
Study Start Date: November 2010
Estimated Study Completion Date: December 2015
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: NEMS group Procedure: NEMS
NEMS sessions on both lower extremities (quadriceps and peroneus longus) simultaneously
Other Name: Neuromuscular Electrical stimulation
Sham Comparator: Sham group Procedure: Sham
Sham sessions of neuromuscular electrical stimulation
Other Name: Sham neuromuscular electrical stimulation

Detailed Description:

Survivors of critical illness are presented with significant physical impairment that is associated with reduced functional ability and health -related quality of life both in the short and long-term.

Neuromuscular electrical stimulation (NEMS) has been proposed as an alternative exercise modality in patients with severe chronic obstructive pulmonary disease and chronic heart failure, who cannot perform active exercise. NEMS has also been used as a preventive tool for intensive care unit (ICU) acquired weakness (ICUAW). Its role as a tool for post ICU rehabilitation has not been evaluated so far.

A randomized intervention study was designed to assess the efficacy of NEMS, as a rehabilitative tool for critical illness survivors. The first day that patients are discharged from the ICU after stratified randomization are assigned to the NEMS group or to the control group. In the NEMS group, NEMS will be applied to both lower extremities of the NEMS -group simultaneously (quadriceps femoris muscle and peroneus longus) on a daily basis, along with a personalized exercise program. NEMS sessions will continue until patient discharge from hospital. In the control group, sham NEMS will be applied along with standard care when it comes to physiotherapy. At hospital discharge patients of both groups of will receive a rehabilitation booklet. Patients on the NEMS group that have significant muscle weakness will have NEMS sessions at home for a period of 2 months. Patients are evaluated at 3 and 6 months after hospital discharge


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients under mechanical ventilation for> 72hours during ICU stay
  • Patients able to perform simple commands (able to be evaluated by MRC scale)

Exclusion Criteria:

  • age < 18 > 85 years
  • pregnancy
  • pre-existing neuromuscular disease (e.g. Gravis)
  • fractures or skin lesions that do not allow the implementation of NEMS
  • presence of pacemaker or defibrillator
  • fractures of spine that so not allow mobilization
  • BMI > 35 kg/m2
  • terminal disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01717833

First Critical Care Unit, Evaggelismos Hospital, School of Medicine
Athens, Greece
Sponsors and Collaborators
University of Athens
Principal Investigator: Serafim Nanas, Professor University of Athens
  More Information

Responsible Party: Serafim Nanas, Professor, University of Athens Identifier: NCT01717833     History of Changes
Other Study ID Numbers: SN01032010
Study First Received: October 21, 2012
Last Updated: June 17, 2015

Keywords provided by Serafim Nanas, University of Athens:
ICU acquired weakness
Critical illness polyneuromyopathy
post ICU rehabilitation
neuromuscular electrical rehabilitation

Additional relevant MeSH terms:
Critical Illness
Disease Attributes
Pathologic Processes processed this record on August 16, 2017